Glossary
Key terms used in product materials and calcium health information. These are general explanations; please refer to the current label and medical advice for actual use.
- Complexation
- In formulation research on compound calcium carbonate granules, this refers to reactions involving calcium carbonate and citric-acid-related components in water. The studies examine dissolution and calcium absorption under defined experimental conditions.
- Inclusion
- A formulation technique that forms an inclusion system with a carrier. The related 2023 pharmaceutical study used beta-cyclodextrin with vitamin D3 and examined stability.
- Calcium citrate complex
- A research term describing the calcium complex system after preparation in water. It is distinct from the ingredient names on the medicine label: LiZhiZhu lists calcium carbonate and vitamin D3.
- Elemental calcium
- The amount of calcium element supplied, rather than the total weight of its compound. Each LiZhiZhu sachet contains 0.75 g calcium carbonate, equivalent to approximately 0.3 g elemental calcium.
- 25-hydroxyvitamin D [25(OH)D]
- A metabolite of vitamin D. Its serum concentration is commonly used to assess vitamin D status and should be interpreted in the clinical context.
- Nutritional rickets
- Impaired bone mineralisation in children associated with vitamin D deficiency and/or inadequate calcium intake. The 2016 global consensus addresses prevention, diagnosis and management; treatment is individualised by a physician.
- Bone mineral density Z-score
- The number of standard deviations between a person’s bone mineral density and an age- and sex-matched reference population. Interpretation also considers age, measurement site and clinical history.
- Prescription medicine
- A medicine supplied on a physician’s prescription and used under professional guidance. LiZhiZhu Compound Calcium Carbonate Granules is a prescription medicine; see product information for its use and precautions.
- Approval No. H20173214
- The approval number for LiZhiZhu Compound Calcium Carbonate Granules manufactured by Wuhan Ximo Pharmaceutical Co., Ltd. Check it alongside the generic name, manufacturer and strength.
LiZhiZhu® Compound Calcium Carbonate Granules is a prescription drug (Approval No. H20173214). Please use it under the guidance of a physician or pharmacist and read the label carefully. This page does not constitute medical advice.
